H3 K27m clinical trials

Explore recruiting h3 k27m clinical trials.

Recruiting h3 k27m studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

H3 K27m trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)

Netherlands, Germany, Italy, Spain, Denmark, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

H3 K27m trials by city

H3 K27m in Toronto H3 K27m in Vancouver H3 K27m in Montreal H3 K27m in Calgary H3 K27m in Edmonton H3 K27m in Ottawa H3 K27m in Winnipeg H3 K27m in Quebec City H3 K27m in Hamilton H3 K27m in Kitchener H3 K27m in London H3 K27m in Halifax H3 K27m in New York H3 K27m in Los Angeles H3 K27m in Chicago H3 K27m in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease